LPIGLM,
Lys-Phe-Ile-Gly-Leu-Met-amide,
lysyl-phenylalanyl-isoleucyl-glycyl-leucyl-methioninamide,
lysyl-phenylalanyl-isoleucyl-glycyl-leucyl-methioninamide dihydrochloride,
lysyl-phenylalanyl-isoleucyl-glycyl-leucyl-methioninamide dihydrochloride, (D-Lys)-isomer,
lysyl-phenylalanyl-isoleucyl-glycyl-leucyl-methioninamide monohydrochloride,
Eledoisin Related Peptide,
Eledoisin-Related Peptide,
2990-43-4,
Lysyl-phenylalanyl-isoleucyl-glycyl-leucyl-methioninamide,
Lpiglm,
Lys-phe-ile-gly-leu-met-amide,
Eledoisine-related peptide,
AC1L45L3,
DTXSID60184017,
HY-P1186,
MFCD00076374,
ZINC85427178,
AKOS024456857,
CS-0028920,
L-Methioninamide, L-lysyl-L-phenylalanyl-L-isoleucylglycyl-L-leucyl-,
(2S)-2,6-diamino-N-[(2S)-1-[[(2S,3S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]hexanamide,
(S)-2,6-diamino-N-((5S,8S,14S,17S)-14-sec-butyl-5-carbamoyl-8-isobutyl-7,10,13,16-tetraoxo-18-phenyl-2-thia-6,9,12,15-tetraazaoctadecan-17-yl)hexanamide,
C34H58N8O6S,
C34-H58-N8-O6-S,
CID151058,
B5233,
L-lysyl-L-phenylalanyl-L-isoleucylglycyl-L-leucyl-L-methioninamide,